Format

Send to

Choose Destination
JAAD Case Rep. 2018 Aug 9;4(7):669-671. doi: 10.1016/j.jdcr.2018.06.022. eCollection 2018 Aug.

Pityriasis rubra pilaris-like erythroderma in the setting of pembrolizumab therapy responsive to acitretin.

Author information

1
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
2
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
3
Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.

KEYWORDS:

IL, interleukin; PD-1, programmed death 1; PRP, pityriasis rubra pilaris; Th, helper T cell; acitretin; immune-related adverse event; irAE, immune-related adverse event; pembrolizumab; pityriasis rubra pilaris

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center